Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Lipid Absorption
Bioavailability Enhancement: Drug Permeability Enhancement
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Michael C Honigberg1,2,3,4, Pradeep Natarajan1,2,3,4
1Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston.
No abstract available in PubMed .